Summaries for patients. Factors associated with Helicobacter pylori infections in the United States that are resistant to usual antibiotics.

Abstract

Summaries for Patients1 January 2002Factors Associated with Helicobacter pylori Infections in the United States That Are Resistant to Usual AntibioticsSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-136-1-200201010-00003 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail What is the problem and what is known about it so far?Helicobacter pylori is a type of bacteria that can cause stomach ulcers. Infection with H. pylori is usually successfully treated with a combination of several antibiotics. However, some H. pylori bacteria are able to grow despite treatment with the usual antibiotics. Such bacteria are “antibiotic resistant.” If doctors knew the information that predicts when a patient will be resistant to treatment, they could be alert for possible resistance before they treat a patient who is at high risk for infection by resistant bacteria. However, no one has fully ... Author, Article, and Disclosure InformationAffiliations: The summary below is from the full report titled “Risk Factors for Helicobacter pylori Resistance in the United States: The Surveillance of H. pylori Antimicrobial Resistance Partnership (SHARP) Study, 1993–1999.” It is in the 1 January 2002 issue of Annals of Internal Medicine (volume 136, pages 13-24). The authors are JM Meyer, NP Silliman, W Wang, NY Siepman, JE Sugg, D Morris, J Zhang, H Bhattacharyya, EC King, and RJ Hopkins.Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoRisk Factors for Helicobacter pylori Resistance in the United States: The Surveillance of H. pylori Antimicrobial Resistance Partnership (SHARP) Study, 1993–1999 Joette M. Meyer , Nancy P. Silliman , Wenjin Wang , Nancy Y. Siepman , Jennifer E. Sugg , David Morris , Jie Zhang , Helen Bhattacharyya , Eileen C. King , and Robert J. Hopkins Metrics Cited byWhat are the global response rates to Helicobacter pylori eradication therapy? 1 January 2002Volume 136, Issue 1Page: I-67KeywordsAntibioticsAntimicrobial resistanceBacteriaGastric ulcersHelicobacter pyloriHelicobacter pylori infectionMedical risk factorsRacial and ethnic issuesRisk managementUlcers ePublished: 1 January 2002 Issue Published: 1 January 2002 Copyright & PermissionsCopyright © 2002 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...